| Literature DB >> 35515780 |
Debolina Chakraborty1, K R Ethiraj1, Amitava Mukherjee2.
Abstract
Over the past few decades, nanoparticle-based therapeutic and diagnostic systems have gained immense recognition. A relative improvement in the status of the global cancer burden has been successful due to the advent of nanoparticle-based formulations. However, exposure of nanoparticles (NPs) to a real-time biological media alters its native identity due to the formation of the biomolecular corona. Such biological interactions hinder the efficiency of the NPs system. The parameters that govern such intricate interaction are generally overlooked while designing nano drugs and delivery systems (nano-DDS). Fabricating nano-DDS with prolonged circulation time, enhanced drug-loading, and release capacity along with efficient clearance, remain the primary concerns associated with cancer therapeutics. This present review firstly aims to summarize the critical aspects that influence protein coronation on therapeutic nanoparticles designed for anti-cancer therapy. The role of protein corona in modifying the overall pharmacodynamics of the nanoparticle-based DDS has been discussed. Further, the studies and patents that extend the concept of protein corona into diagnostics have been elaborated. An understanding of the pros and cons associated with protein coronation would not only help us gain better insights into the fabrication of effective anti-cancer drug-delivery systems but also improve the shortcomings related to the clinical translation of these nanotherapeutics. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35515780 PMCID: PMC9055466 DOI: 10.1039/d0ra05241h
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Graphical representation of studies on protein corona formation on different nanoparticles over the past 5 years.
Scheme 1Schematic representation showing nanoparticle–protein interaction and properties of bound corona proteins.
Characteristics of soft and hard corona
| Parameter | Soft corona | Hard corona |
|---|---|---|
| Type of adherence to the NPs | Loose (indirectly associated with NPs | Tight (directly associated with the NPs |
| Dissociation constant | High, dynamic in nature | Low, strongly associated with the NPs surface |
| Structural changes | A lower degree of conformational changes observed | A higher degree of conformational changes are observed |
| Mode of detection | Liquid chromatography with tandem mass spectrometry (LC-MS/MS), protein quantification by bicinchoninic acid (BCA)/Bradford assay | Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), LC-MS/MS, transmission electron microscopy (TEM), fluorescence correlation spectroscopy (FCS) |
| Isolation from NPs surface | Sucrose-gradient centrifugation, ultra-centrifugation | Treatment with laemmli buffer followed by heating and centrifugation |
Summary of the mechanism of protein corona formation on different NPs
| Nanoparticle type | Protein source | Mechanism of protein corona formation | Ref. |
|---|---|---|---|
| Sulfonate and carboxyl-polystyrene NPs | Transferrin and blood plasma | Exchange of transferrin from the soft corona layer in the presence of different concentration of blood plasma |
|
| Polystyrene NPs | Cellulase enzyme mixture | Vroman effect showing displacement of proteins along with transient complex formation |
|
| Oil-in-water emulsion | Human plasma | No displacement of proteins was observed. Apolipoproteins were dominantly present in the corona component |
|
| Citrate capped gold NPs | Ubiquitin | A combinatorial effect of NPs electrostatic potential, surface coating and slow reorientation of the NPs to find ubiquitin's specific binding site promotes corona formation |
|
| Citrate-capped gold NPs with PEG coating | Human plasma | No competitive displacement of proteins were observed. Quantitative variation in bound protein due to surface coating was observed |
|
| Metal oxide NPs (TiO2, SiO2, ZnO) | Human plasma | No typical Vroman effect was observed. Shape of the NPs played important role in adsorption of particular class of proteins |
|
| Ultrasmall supermagnetic iron oxide nanoparticles (USPIO) | Plasma | No typical Vroman effect was observed. An increase in the amount of immunoglobin and fibrinogen was observed for longer incubation time points |
|
Scheme 2Schematic representation showing the external media conditions and intrinsic property of the NPs that influence protein corona formation.
Scheme 3Summary of the role of protein corona in nanomedicine.
Patents involving protein corona based disease screening and diagnosis
| Inventors | Title | Application no. | Ref. |
|---|---|---|---|
| O. C. Farokhzad, M. Mahmoudi | System and method for protein corona sensor array for early detection of diseases | WO2018112460A1 |
|
| Q. Huo | Methods for biomolecule and biomolecule complex (bmc) detection and analysis and the use of such for research and medical diagnosis | WO2011088128A2 |
|
| K. Dawson, L. Lynch, M. Lundqvist, T. Cedervall | A method for the selective concentration of a specific low abundance biomolecule | WO2010097785A1 |
|
| K. Kostarelos, M. Hadjidemetriou | Detection of cancer biomarkers using nanoparticles | WO2018046542A1 |
|
| Q. Huo | Biomolecular interactions and interaction products as biomarkers for detection, diagnosis, prognosis and predicting therapeutic responses of human diseases | US20130058923A1 |
|